The global vascular patches market is growing at significant rate, due to mounting occurrence vascular diseases and mounting acceptance of biological patches.
Mounting occurrence of vascular diseases, and escalating number of vascular surgeries performed are the primary growth drivers for vascular patches market. Abdominal aortic aneurysm, carotid artery disease and peripheral artery disease are the major vascular diseases. According to Society of Vascular Surgery, 80 percent of strokes are usually due to blockages in the carotid arteries.
In addition, mounting acceptance of biological patches is also driving the growth of the market. The biological patches are biocompatible and are exceptionally tensile. It does not require special sutures and is similar to autologous tissue.
Expanding geriatric population and mounting healthcare spending and refining healthcare infrastructure in developing economies are also facilitating the growth for the vascular patches market. For instance, according to World Health Organization (WHO), globally in 2010 approximately 524 million people were aged 65 years and older, and is expected to reach 1.5 billion in 2050.
North America is the largest vascular patches market as in the region the geriatric population is increasing.
LeMaitre Vascular, C. R. Bard, Terumo Corporation, Baxter International, Admedus, Edwards Lifesciences, Maquet, Edwards Lifesciences, W. L. Gore & Associates, Labcor, B.Braun, and Cryolife are the key players offering vascular patches.
Source: VynZ Research
Like it? Share it!
About the Author
Yash Chauhan Joined: February 25th, 2019 Articles Posted: 106
